| A new sea anemone peptide, APETx2, inhibits ASIC3, a major acid‐sensitive channel in sensory neurons S Diochot, A Baron, LD Rash, E Deval, P Escoubas, S Scarzello, ... The EMBO journal 23 (7), 1516-1525, 2004 | 433 | 2004 |
| Pharmacology and biochemistry of spider venoms LD Rash, WC Hodgson Toxicon 40 (3), 225-254, 2002 | 427 | 2002 |
| The concise guide to pharmacology 2019/20: Ion channels SPH Alexander, A Mathie, JA Peters, EL Veale, J Striessnig, E Kelly, ... British journal of pharmacology 176, S142-S228, 2019 | 342 | 2019 |
| Spider-venom peptides as therapeutics NJ Saez, S Senff, JE Jensen, SY Er, V Herzig, LD Rash, GF King Toxins 2 (12), 2851-2871, 2010 | 333 | 2010 |
| Tarantulas: eight-legged pharmacists and combinatorial chemists P Escoubas, L Rash Toxicon 43 (5), 555-574, 2004 | 247 | 2004 |
| Venomics: a new paradigm for natural products-based drug discovery I Vetter, JL Davis, LD Rash, R Anangi, M Mobli, PF Alewood, RJ Lewis, ... Amino acids 40, 15-28, 2011 | 245 | 2011 |
| The concise guide to pharmacology 2021/22: Ion channels SPH Alexander, A Mathie, JA Peters, EL Veale, J Striessnig, E Kelly, ... British Journal of Pharmacology 178, S157-S245, 2021 | 229 | 2021 |
| Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a IR Chassagnon, CA McCarthy, YKY Chin, SS Pineda, A Keramidas, ... Proceedings of the National Academy of Sciences 114 (14), 3750-3755, 2017 | 194 | 2017 |
| Four novel tarantula toxins as selective modulators of voltage-gated sodium channel subtypes F Bosmans, L Rash, S Zhu, S Diochot, M Lazdunski, P Escoubas, J Tytgat Molecular pharmacology 69 (2), 419-429, 2006 | 177 | 2006 |
| Production of recombinant disulfide-rich venom peptides for structural and functional analysis via expression in the periplasm of E. coli JK Klint, S Senff, NJ Saez, R Seshadri, HY Lau, NS Bende, EAB Undheim, ... PloS one 8 (5), e63865, 2013 | 173 | 2013 |
| The diversity of venom: the importance of behavior and venom system morphology in understanding its ecology and evolution V Schendel, LD Rash, RA Jenner, EAB Undheim Toxins 11 (11), 666, 2019 | 168 | 2019 |
| Mutations in the voltage-gated potassium channel gene KCNH1 cause Temple-Baraitser syndrome and epilepsy C Simons, LD Rash, J Crawford, L Ma, B Cristofori-Armstrong, D Miller, ... Nature genetics 47 (1), 73-77, 2015 | 145 | 2015 |
| NaV1. 7 as a pain target–from gene to pharmacology I Vetter, JR Deuis, A Mueller, MR Israel, H Starobova, A Zhang, LD Rash, ... Pharmacology & therapeutics 172, 73-100, 2017 | 134 | 2017 |
| Inhibition of voltage‐gated Na+ currents in sensory neurones by the sea anemone toxin APETx2 MG Blanchard, LD Rash, S Kellenberger British journal of pharmacology 165 (7), 2167-2177, 2012 | 105 | 2012 |
| A dynamic pharmacophore drives the interaction between Psalmotoxin-1 and the putative drug target acid-sensing ion channel 1a NJ Saez, M Mobli, M Bieri, IR Chassagnon, AK Malde, R Gamsjaeger, ... Molecular pharmacology 80 (5), 796-808, 2011 | 102 | 2011 |
| The receptor site of the spider toxin PcTx1 on the proton‐gated cation channel ASIC1a M Salinas, LD Rash, A Baron, G Lambeau, P Escoubas, M Lazdunski The Journal of physiology 570 (2), 339-354, 2006 | 101 | 2006 |
| Acid-sensing ion channel (ASIC) structure and function: Insights from spider, snake and sea anemone venoms B Cristofori-Armstrong, LD Rash Neuropharmacology 127, 173-184, 2017 | 92 | 2017 |
| Neurotoxicity and other pharmacological activities of the snake venom phospholipase A2 OS2: the N-terminal region is more important than enzymatic activity M Rouault, D Lachlan, P Escoubas, E Boilard, J Bollinger, B Lomonte, ... Biochemistry 45 (18), 5800-5816, 2006 | 81 | 2006 |
| Chemical synthesis, 3D structure, and ASIC binding site of the toxin mambalgin‐2 CI Schroeder, LD Rash, X Vila‐Farrés, KJ Rosengren, M Mobli, GF King, ... Angewandte Chemie International Edition 53 (4), 1017-1020, 2014 | 79 | 2014 |
| PcTx1 affords neuroprotection in a conscious model of stroke in hypertensive rats via selective inhibition of ASIC1a CA McCarthy, LD Rash, IR Chassagnon, GF King, RE Widdop Neuropharmacology 99, 650-657, 2015 | 66 | 2015 |
Mehdi MobliProfessor, The University of QueenslandVerified email at uq.edu.au
